271 related articles for article (PubMed ID: 19524120)
21. CAML promotes prolactin-dependent proliferation of breast cancer cells by facilitating prolactin receptor signaling pathways.
Lim JH; Kim TY; Kim WH; Park JW
Breast Cancer Res Treat; 2011 Nov; 130(1):19-27. PubMed ID: 21128111
[TBL] [Abstract][Full Text] [Related]
22. Prolactin receptor targeting in breast and prostate cancers: New insights into an old challenge.
Goffin V
Pharmacol Ther; 2017 Nov; 179():111-126. PubMed ID: 28549597
[TBL] [Abstract][Full Text] [Related]
23. Prolactin and the prolactin receptor: new targets of an old hormone.
Harris J; Stanford PM; Oakes SR; Ormandy CJ
Ann Med; 2004; 36(6):414-25. PubMed ID: 15513293
[TBL] [Abstract][Full Text] [Related]
24. Neutralization of prolactin receptor function by monoclonal antibody LFA102, a novel potential therapeutic for the treatment of breast cancer.
Damiano JS; Rendahl KG; Karim C; Embry MG; Ghoddusi M; Holash J; Fanidi A; Abrams TJ; Abraham JA
Mol Cancer Ther; 2013 Mar; 12(3):295-305. PubMed ID: 23270929
[TBL] [Abstract][Full Text] [Related]
25. Prolactin signaling through focal adhesion complexes is amplified by stiff extracellular matrices in breast cancer cells.
Barcus CE; Keely PJ; Eliceiri KW; Schuler LA
Oncotarget; 2016 Jul; 7(30):48093-48106. PubMed ID: 27344177
[TBL] [Abstract][Full Text] [Related]
26. [Prolactin and serotonin].
Lychkovq AE; Puzikov AM
Vestn Ross Akad Med Nauk; 2014; (1-2):38-45. PubMed ID: 25055559
[TBL] [Abstract][Full Text] [Related]
27. Diphenylbutylpiperidine Antipsychotic Drugs Inhibit Prolactin Receptor Signaling to Reduce Growth of Pancreatic Ductal Adenocarcinoma in Mice.
Dandawate P; Kaushik G; Ghosh C; Standing D; Ali Sayed AA; Choudhury S; Subramaniam D; Manzardo A; Banerjee T; Santra S; Ramamoorthy P; Butler M; Padhye SB; Baranda J; Kasi A; Sun W; Tawfik O; Coppola D; Malafa M; Umar S; Soares MJ; Saha S; Weir SJ; Dhar A; Jensen RA; Thomas SM; Anant S
Gastroenterology; 2020 Apr; 158(5):1433-1449.e27. PubMed ID: 31786131
[TBL] [Abstract][Full Text] [Related]
28. Prolactin Pro-Differentiation Pathway in Triple Negative Breast Cancer: Impact on Prognosis and Potential Therapy.
López-Ozuna VM; Hachim IY; Hachim MY; Lebrun JJ; Ali S
Sci Rep; 2016 Aug; 6():30934. PubMed ID: 27480353
[TBL] [Abstract][Full Text] [Related]
29. Involvement of prolactin in breast cancer: redefining the molecular targets.
Llovera M; Touraine P; Kelly PA; Goffin V
Exp Gerontol; 2000 Feb; 35(1):41-51. PubMed ID: 10705038
[TBL] [Abstract][Full Text] [Related]
30. Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice.
Bole-Feysot C; Goffin V; Edery M; Binart N; Kelly PA
Endocr Rev; 1998 Jun; 19(3):225-68. PubMed ID: 9626554
[TBL] [Abstract][Full Text] [Related]
31. The prolactin receptor mediates HOXA1-stimulated oncogenicity in mammary carcinoma cells.
Hou L; Xu B; Mohankumar KM; Goffin V; Perry JK; Lobie PE; Liu DX
Int J Oncol; 2012 Dec; 41(6):2285-95. PubMed ID: 23064471
[TBL] [Abstract][Full Text] [Related]
32. [Effects of acupuncture combined with
Zhao X; Hou M
Zhongguo Zhen Jiu; 2017 Dec; 37(12):1309-14. PubMed ID: 29354997
[TBL] [Abstract][Full Text] [Related]
33. Prolactin receptor signaling is essential for perinatal brown adipocyte function: a role for insulin-like growth factor-2.
Viengchareun S; Servel N; Fève B; Freemark M; Lombès M; Binart N
PLoS One; 2008 Feb; 3(2):e1535. PubMed ID: 18253483
[TBL] [Abstract][Full Text] [Related]
34. The many faces of prolactin in breast cancer.
Chen WY
Adv Exp Med Biol; 2015; 846():61-81. PubMed ID: 25472534
[TBL] [Abstract][Full Text] [Related]
35. Association of prolactin and its receptor gene regions with familial breast cancer.
Vaclavicek A; Hemminki K; Bartram CR; Wagner K; Wappenschmidt B; Meindl A; Schmutzler RK; Klaes R; Untch M; Burwinkel B; Försti A
J Clin Endocrinol Metab; 2006 Apr; 91(4):1513-9. PubMed ID: 16434456
[TBL] [Abstract][Full Text] [Related]
36. Triennial Lactation Symposium: Prolactin: The multifaceted potentiator of mammary growth and function.
Trott JF; Schennink A; Petrie WK; Manjarin R; VanKlompenberg MK; Hovey RC
J Anim Sci; 2012 May; 90(5):1674-86. PubMed ID: 22205663
[TBL] [Abstract][Full Text] [Related]
37. Prolactin-growth factor crosstalk reduces mammary estrogen responsiveness despite elevated ERalpha expression.
Arendt LM; Grafwallner-Huseth TL; Schuler LA
Am J Pathol; 2009 Mar; 174(3):1065-74. PubMed ID: 19179608
[TBL] [Abstract][Full Text] [Related]
38. Prolactin (PRL) and prolactin receptor (PRLR) genes and their role in poultry production traits.
Wilkanowska A; Mazurowski A; Mroczkowski S; Kokoszyński D
Folia Biol (Krakow); 2014; 62(1):1-8. PubMed ID: 24745142
[TBL] [Abstract][Full Text] [Related]
39. Should prolactin be reconsidered as a therapeutic target in human breast cancer?
Goffin V; Touraine P; Pichard C; Bernichtein S; Kelly PA
Mol Cell Endocrinol; 1999 May; 151(1-2):79-87. PubMed ID: 10411322
[TBL] [Abstract][Full Text] [Related]
40. The prolactin receptor as a therapeutic target in human diseases: browsing new potential indications.
Goffin V; Touraine P
Expert Opin Ther Targets; 2015; 19(9):1229-44. PubMed ID: 26063597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
